0      0

Pandemic’s Impact for Supply Chain

‐ Jan 26, 2022 12:15pm

Supply of raw materials has been a risk to the biomanufacturing industry for many years, however, the pandemic has worsened and accelerated what is now no longer a risk but a reality.

The session will explore how industry and the regulators are mitigating risks for the current and future state of the raw material supply chain; three perspectives will be shared, that of suppliers, end users and regulators.

Session Speakers:
10:45 - 11:10
Managing Raw Material Supply Chain Challenges during the COVID-19 Pandemic and Resulting Future Opportunities - A Roche Perspective
V Stefan Paschen, Roche Diagnostics GmbH

11:10 - 11:35
Supplying an mRNA COVID 19 Vaccine at Unprecedented Pace and Scale
V David Sullivan, Pfizer, Inc.

11:35 - 12:00
Regulatory Approaches to Manage Supply Chain Challenges
V Patricia Hughes, CDER, FDA

12:00 - 12:15
Discussion - Questions and Answers


Session Chair(s):

You must be logged in and own this session in order to post comments.